OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study
Hauke Basedau, Kuan‐Po Peng, Marlene Schellong, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Hauke Basedau, Kuan‐Po Peng, Marlene Schellong, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Showing 4 citing articles:
Unveiling the efficacy and safety of Erenumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, in patients with chronic and episodic migraine: a GRADE-assessed systematic review and meta-analysis of randomized clinical trials with subgroup analysis
Mohamed E. Haseeb, Hazem E. Mohammed, Hatem Yaser, et al.
Head & Face Medicine (2025) Vol. 21, Iss. 1
Open Access
Mohamed E. Haseeb, Hazem E. Mohammed, Hatem Yaser, et al.
Head & Face Medicine (2025) Vol. 21, Iss. 1
Open Access
The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review
Abimael González‐Hernández, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2024)
Closed Access | Times Cited: 2
Abimael González‐Hernández, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2024)
Closed Access | Times Cited: 2
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2024) Vol. 38, Iss. 7, pp. 533-546
Closed Access | Times Cited: 1
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2024) Vol. 38, Iss. 7, pp. 533-546
Closed Access | Times Cited: 1
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup Analysis
Mohamed E. Haseeb, Hazem E. Mohammed, Hatem Yaser, et al.
Research Square (Research Square) (2024)
Open Access
Mohamed E. Haseeb, Hazem E. Mohammed, Hatem Yaser, et al.
Research Square (Research Square) (2024)
Open Access
